• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

xiaowei.wang@unimelb.edu.au

Credentials


Position
Laboratory Head, Molecular Imaging & Theranostics
Baker Department of Cardiometabolic Health
Education
PhD
Monash University
PhD
Monash University
Bachelors Degree (Honours)
University of Melbourne
ORCID

0000-0001-8658-7399

Prof Xiaowei Wang

Laboratory Head, Molecular Imaging & Theranostics
Baker Department of Cardiometabolic Health

152 Scholarly works
8 Projects

HIGHLIGHTS

  • 2026

    Journal article

    A Safe and Long-circulating Dual Antiplatelet/anticoagulant Drug for Enhanced and Prolonged Thromboprophylaxis and Cardiac Protection
    DOI: 10.1016/j.jmccpl.2025.100627
  • 2026

    Journal article

    Platelet membrane microbubbles as ultrasound imaging-trackable colloidal agents for clot targeting and detection
    DOI: 10.1016/j.jmccpl.2025.100534
  • 2026

    Journal article

    Precision mRNA Delivery via Ultrasound-Controlled Release Perfluorocarbon Emulsions: An Innovative Ultrasound Theranostic Strategy with 19F MRI Feasibility
    DOI: 10.1002/smll.202506806
  • 2026

    Journal article

    Precision mRNA Delivery via Ultrasound‐Controlled Release Perfluorocarbon Emulsions: An Innovative Ultrasound Theranostic Strategy with 19 F MRI Feasibility (Small 11/2026)
    DOI: 10.1002/smll.72781
  • 2025

    Research grants (other domestic)

    Precision Prevention: Novel mRNA Encoding Platelet Blocking Antibody for Targeted Thrombosis Management
  • 2023

    Research grants (other domestic)

    Personalised Medicine for Cardiovascular Diseases
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Novel Targeted Anti-Inflammatory and Anti-Thrombotic mRNA-based Approaches to Combat Cardiovascular Diseases
Xiaowei Wang

Latest Honours,
Awards and Fellowships


2023
National Heart Foundation Future Leader Fellowship 2
2022
Fellow of the European Society Of Cardiology (FESC)
2019
Baker Sir Lawrence Muir Award for Outstanding Research
2019
Alfred Research Alliance Publication Prize

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery
    DOI: 10.1002/smll.202511946
  • 2026

    Journal article

    Mapping Hydration and Nanoarchitecture in mRNA-Loaded Lipid Nanoparticles Through Small-Angle Neutron Scattering
    DOI: 10.1002/sstr.202500636
  • 2025

    Journal article

    Unlocking the Architecture and Component Distribution of Bioengineered and Derived Colloidal Structures from Blood with Neutron Scattering
    DOI: 10.1002/sstr.202500369
  • 2025

    Journal article

    TCR-dependent CD8 T cell responses drive atherosclerotic plaque instability 2443
    DOI: 10.1093/jimmun/vkaf283.361
  • 2025

    Journal article

    CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion
    DOI: 10.1093/cvr/cvaf165
  • 2025

    Journal article

    Abstract Wed143: Acetylcholine-loaded Nanoparticles Protect Against Myocardial Injury In In Vitro Cardiac Spheroids and In an I n Vivo Myocardial Infarction Murine Model
    DOI: 10.1161/res.137.suppl_1.wed143

RECENT PROJECTS

  • 2026

    Research grants (other domestic)

    mRNA-Based Immunomodulatory Nanoparticles as a Therapeutic Strategy for Post-Stroke Recovery
  • 2024

    Research grants (other domestic)

    Novel mRNA-based Therapeutics: An Innovative Controlled-Release Nanodelivery Approach to Treat Inflammation-Related Cardiovascular Diseases

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224